SkinBioTherapeutics PLC Financial Flexibility Index
SkinBioTherapeutics PLC financial flexibility index. SkinBioTherapeutics PLC (SBTX) has a Financial Flexibility Index of -0.18x as of June 2025. Free cash flow of GBX-491.17K (operating CF GBX-494.84K minus capex GBX3.66K) represents 0% of total liabilities (GBX2.71 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SkinBioTherapeutics PLC (2016–2025)
Financial flexibility index of SkinBioTherapeutics PLC from 2016 to 2025. Historical Financial Flexibility Index trend for SkinBioTherapeutics PLC across 10 annual periods. Check cash flow quality index of SkinBioTherapeutics PLC to evaluate the quality of earnings relative to operating cash generation.
SkinBioTherapeutics PLC Financial Flexibility Index by Year (2016–2025)
SkinBioTherapeutics PLC financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for SkinBioTherapeutics PLC. For the full cash flow conversion analysis, see SBTX operating cash flow.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.48x | GBX-1.29 Million | GBX-1.30 Million | GBX2.71 Million | ▲ +57.6% |
| 2024 | -1.13x | GBX-2.53 Million | GBX-2.73 Million | GBX2.25 Million | ▲ +72.8% |
| 2023 | -4.14x | GBX-2.48 Million | GBX-2.65 Million | GBX599.34K | ▲ +2.1% |
| 2022 | -4.23x | GBX-2.58 Million | GBX-2.67 Million | GBX609.61K | ▼ -52.2% |
| 2021 | -2.78x | GBX-1.44 Million | GBX-1.56 Million | GBX519.67K | ▼ -3.4% |
| 2020 | -2.69x | GBX-818.47K | GBX-892.14K | GBX304.83K | ▲ +77.0% |
| 2019 | -11.69x | GBX-1.42 Million | GBX-1.43 Million | GBX121.33K | ▼ -310.9% |
| 2018 | -2.85x | GBX-595.49K | GBX-667.75K | GBX209.29K | ▲ +36.4% |
| 2017 | -4.47x | GBX-530.50K | GBX-609.70K | GBX118.66K | ▼ -211.4% |
| 2016 | 4.01x | GBX135.05K | GBX-1.17K | GBX33.64K | — |